View More View Less
  • 1 Semmelweis University, Budapest, Hungary
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

The incidence of Candida bloodstream infection (BSI) has increased during the past decades. Species distribution is changing worldwide, and non-albicans Candida spp. are becoming more prevalent. Acquired resistance to antifungal agents has been documented in several reports. The aim of our study was to assess the epidemiology and antifungal susceptibility of Candida isolates from BSI at our institute. The incidence of Candida BSI increased during the first four years of our investigation, from 1.7 to 3.5 episodes / 10 000 admissions, then dropped to 2.66 episodes / 10 000 admissions in the last year. The most frequently isolated species was C. albicans (63%), followed by C. glabrata (13%), C. parapsilosis (10.2%), C. tropicalis (9.3%), and C. krusei (3.7%). One isolate each of C. kefyr, C. fabianii and C. inconspicua were detected. The percentage of C. albicans remained stable throughout the study period. The most frequent risk factors of Candida BSI in our patient population were intensive care treatment (60.4%), abdominal surgery (52.5%), and solid malignancy (30.7%). All isolates were wild-type organisms, no acquired antifungal resistance was detected.

  • 1.

    Kett, D. H., Azoulay, E., Echeverria, P. M., Vincent, J. L., and for the Extended Prevalence of Infection in the ICU Study (EPIC II) Group of Investigators: Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study. Crit Care Med 39, 665670 (2011).

    • Search Google Scholar
    • Export Citation
  • 2.

    Arendrup, M. C., Bruun, B., Christensen, J. J., Fuursted, K., Johansen, H. K., Kjaeldgaard, P., Knudsen, J. D., Kristensen, L., Møller, J., Nielsen, L., Rosenvinge, F. S., Røder, B., Schønheyder, H. C., Thomsen, M. K., Truberg, K.: National surveillance of fungemia in Denmark (2004 to 2009). J Clin Microbiol 49, 325334 (2011).

    • Search Google Scholar
    • Export Citation
  • 3.

    Puig-Asensio, M., Padilla, B., Garnacho-Montero, J., Zaragoza, O., Aguado, J. M., Zaragoza, R., Montejo, M., Muñoz, P., Ruiz-Camps, I., Cuenca-Estrella, M., Almirante, B.; CANDIPOP Project; GEIH-GEMICOMED (SEIMC); REIPI: Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: A population- based surveillance in Spain. Clin Microbiol Infect 20, 245254 (2014).

    • Search Google Scholar
    • Export Citation
  • 4.

    Sandven, P., Bevanger, L., Digranes, A., Haukland, H. H., Mannsåker, T., Gaustad, P., and the Norwegian Yeast Study Group: Candidemia in Norway (1991 to 2003): Results from a nationwide study. J Clin Microbiol 44, 19771981 (2006).

    • Search Google Scholar
    • Export Citation
  • 5.

    Cleveland, A. A., Farley, M. M., Harrison, L. H., Stein, B., Hollick, R., Lockhart, S. R., Magill, S. S., Derado, G., Park, B. J., Chiller, T. M.: Changes in incidence and antifungal drug resistance in candidemia: Results from population-based laboratory surveillance in Atlanta and Baltimore, 2008–2011. Clin Infect Dis 55, 13521361 (2012).

    • Search Google Scholar
    • Export Citation
  • 6.

    Wisplinghoff, H., Ebbersa, J., Geurtza, L., Stefanik, D., Major, Y., Edmond, M. B., Wenzel, P., Seifert, H.: Nosocomial bloodstream infections due to Candida spp. in the USA: Species distribution, clinical features and antifungal susceptibilities. Int J Antimicrob Agents 43, 7881 (2014).

    • Search Google Scholar
    • Export Citation
  • 7.

    Tapia, G. G., Razonable, R. R., Eckel-Passow, J. E., Lahr, B. D., Afessa, B., Keegan, M. T., Catania, J., Baddour, L. M.: A scoring model of factors associated with Candida glabrata candidemia among critically ill patients. Mycoses 55, 228236 (2012).

    • Search Google Scholar
    • Export Citation
  • 8.

    Chi, H. W., Yang, Y. S., Shang, S. T., Chen, K. H., Yeh, K. M., Chang, F. Y., Lin, J. C.: Candida albicans versus non-albicans bloodstream infections: The comparison of risk factors and outcome. J Microbiol Immunol Infect 44, 369375 (2011).

    • Search Google Scholar
    • Export Citation
  • 9.

    Leenders, N. H., Oosterheert, J. J., Ekkelenkamp, M. B., De Lange, D. W., Hoepelman, A. I., Peters, E. J.: Candidemic complications in patients with intravascular catheters colonized with Candida species: An indication for preemptive antifungal therapy? Int J Infect Dis 15, 453458 (2011).

    • Search Google Scholar
    • Export Citation
  • 10.

    Pfaller, M., Neofytos, D., Diekema, D., Azie, N., Meier-Kriesche, H. U., Quan, S. P., Horn, D.: Epidemiology and outcomes of candidemia in 3648 patients: Data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004–2008. Diagn Microbiol Infect Dis 74, 323331 (2012).

    • Search Google Scholar
    • Export Citation
  • 11.

    Jordá-Marcos, R., Álvarez-Lerma, F., Jurado, M., Palomar, M., Nolla-Salas, J., León, M. A., León, C.; EPCAN Study Group: Risk factors for candidaemia in critically ill patients: A prospective surveillance study. Mycoses 50, 302310 (2007).

    • Search Google Scholar
    • Export Citation
  • 12.

    Labelle, A. J., Micek, S. T., Roubinian, N., Kollef, M. H.: Treatment-related risk factors for hospital mortality in Candida bloodstream infections. Crit Care Med 36, 29672972 (2008).

    • Search Google Scholar
    • Export Citation
  • 13.

    Hii, I. M., Chang, H. L., Lin, L. C., Lee, Y. L., Liu, Y. M., Liu, C. E., Chen, C. H., Cheng, Y. R., Chang, C. Y.: Changing epidemiology of candidemia in a medical center in middle Taiwan. J Microbiol Immunol Infect, http://dx.doi.org/10.1016/j.jmii.2013.08.017 (2013).

    • Search Google Scholar
    • Export Citation
  • 14.

    Ma, C. F., Li, F. Q., Shi, L. N., Hu, Y. A., Wang, Y., Huang, M., Kong, Q. Q.: Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China. BMC Infect Dis 13, 337 (2013).

    • Search Google Scholar
    • Export Citation
  • 15.

    Bassetti, M., Ansaldi, F., Nicolini, L., Malfatto, E., Molinari, M. P., Mussap, M., Rebesco, B., Bobbio Pallavicini, F., Icardi, G., Viscoli, C.: Incidence of candidaemia and relationship with fluconazole use in an intensive care unit. J Antimicrob Chemother 64, 625629 (2009).

    • Search Google Scholar
    • Export Citation
  • 16.

    Lee, I., Fishman, N. O., Zaoutis, T. E., Morales, K. H., Weiner, M. G., Synnestvedt, M., Nachamkin, I., Lautenbach, E.: Risk factors for fluconazole-resistant Candida glabrata bloodstream infections. Arch Intern Med 169, 379383 (2009).

    • Search Google Scholar
    • Export Citation
  • 17.

    Pfeiffer, C. D., Garcia-Effron, G., Zaas, A. K., Perfect, J. R., Perlin, D. S., Alexander, B. D.: Breakthrough invasive Candidiasis in patients on micafungin. J Clin Microbiol 48, 23732380 (2010).

    • Search Google Scholar
    • Export Citation
  • 18.

    Cho, E. J., Shin, J. H., Kim, S. H., Kim, H. K., Park, J. S., Sung, H., Kim, M. N., Im, H. J.: Emergence of multiple resistance profiles involving azoles, echinocandins and amphotericin B in Candida glabrata isolates from a neutropenia patient with prolonged fungaemia. J Antimicrob Chemother 70, 12681270 (2015).

    • Search Google Scholar
    • Export Citation
  • 19.

    The European Committee on Antimicrobial Susceptibility Testing. Antifungal Agents. Breakpoint tables for interpretation of MICs. Version 7.0, 2014. http://www.eucast.org.

    • Search Google Scholar
    • Export Citation
  • 20.

    Wille, M. P., Guimarães, T., Furtado, G. H., Colombo, A. L.: Historical trends in the epidemiology of candidaemia: Analysis of an 11-year period in a tertiary care hospital in Brazil. Mem Inst Oswaldo Cruz 108(3), 288292 (2013).

    • Search Google Scholar
    • Export Citation
  • 21.

    Dóczi, I., Dósa, E., Hajdú, E., Nagy, E.: Aetology and antifungal susceptibility of yeast bloodstream infections in a Hungarian university hospital between 1996 and 2000. I Med Microbiol 51(9), 677681 (2002).

    • Search Google Scholar
    • Export Citation
  • 22.

    Tortorano, A. M., Peman, J., Bernhardt, H., Klingspor, L., Kibbler, C. C., Faure, O., Biraghi, E., Canton, E., Zimmermann, K., Seaton, S., Grillot, R.; ECMM Working Group on Candidaemia: Epidemiology of candidaemiain Europe: Results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 23(4), 317322 (2004).

    • Search Google Scholar
    • Export Citation
  • 23.

    Moretti, M. L., Trabasso, P., Lyra, L., Fagnani, R., Resende, M. R., de Oliveira Cardoso, L. G., Schreiber, A. Z.: Is the incidence of candidemia caused by Candida glabrata increasing in Brazil? Five-year surveillance of Candida bloodstream infection in a university reference hospital in southeast Brazil. Med Mycol 51(3), 225230 (2013).

    • Search Google Scholar
    • Export Citation
  • 24.

    Kuhns, M., Rosenberger, A., Bader, O., Reichard, U., Gross, U., Weig, M.: Incidence of Candidaemia following abdominal surgery in German hospitals. Zentralbl Chir 2013 Nov 15. [in German]

    • Search Google Scholar
    • Export Citation
  • 25.

    Posteraro, B., De Pascale, G., Tumbarello, M., Torelli, R., Pennisi, M. A., Bello, G., Maviglia, R., Fadda, G., Sanguinetti, M., Antonelli, M.: Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1-3)-ß-D-glucan assay, Candida score, and colonization index. Crit Care 15(5), R249 (2011).

    • Search Google Scholar
    • Export Citation
  • 26.

    Pulimood, S., Ganesan, L., Alangaden, G., Chandrasekar, P.: Polymicrobial candidemia. Diagn Microbiol Infect Dis 44(4), 353357 (2002)

    • Search Google Scholar
    • Export Citation
  • 27.

    Cho, E. J., Shin, J. H., Kim, S. H., Kim, H. K., Park, J. S., Sung, H., Kim, M. N., Im, H. J.: Emergence of multiple resistance profiles involving azoles, echinocandins and amphotericin B in Candida glabrata isolates from a neutropenia patient with prolonged fungaemia. J Antimicrob Chemother 70(4), 12681270 (2015).

    • Search Google Scholar
    • Export Citation
  • 28.

    Cleveland, A. A., Harrison, L. H., Farley, M. M., Hollick, R., Stein, B., Chiller, T. M., Lockhart, S. R., Park, B. J.: Declining incidence of Candidemia and the shifting epidemiology of candida resistance in two US metropolitan areas, 2008–2013: Results from population-based surveillance. PLoS One 10(3), e0120452 (2015).

    • Search Google Scholar
    • Export Citation
  • 29.

    Pfaller, M., Neofytos, D., Diekema, D., Azie, N., Meier-Kriesche, H. U., Quan, S. P., Horn, D.: Epidemiology and outcomes of candidemia in 3648 patients: Data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004–2008. Diagn Microbiol Infect Dis 74, 323331 (2012).

    • Search Google Scholar
    • Export Citation
  • 30.

    Das, I., Nightingale, P., Patel, M., Jumaa, P.: Epidemiology, clinical characteristics, and outcome of candidemia: Experiencein a tertiary referral center in the UK. Int J Infect Dis 15(11), 759763 (2011).

    • Search Google Scholar
    • Export Citation
  • 31.

    Arendrup, M., Horn, T., Frimodt-Møller, N.: In vivo pathogenicity of eight medically relevant Candida species in an animal model. Infection 30(5), 286291 (2002).

    • Search Google Scholar
    • Export Citation

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
sumbission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2021 Online subsscription: 652 EUR / 812 USD
Subscription fee 2022 Online subsscription: 662 EUR / 832 USD
Print + online subscription: 740 EUR / 930 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Apr 2021 17 0 0
May 2021 2 0 0
Jun 2021 7 0 0
Jul 2021 1 0 0
Aug 2021 7 0 0
Sep 2021 8 0 0
Oct 2021 0 0 0